Connection

Susan Dorman to Isoniazid

This is a "connection" page, showing publications Susan Dorman has written about Isoniazid.
Connection Strength

2.425
  1. Latent Tuberculosis Infection. N Engl J Med. 2021 12 09; 385(24):2271-2280.
    View in: PubMed
    Score: 0.797
  2. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009 Aug 01; 180(3):273-80.
    View in: PubMed
    Score: 0.333
  3. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007 Oct; 45(10):3387-9.
    View in: PubMed
    Score: 0.296
  4. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Arch Intern Med. 2006 Sep 25; 166(17):1863-70.
    View in: PubMed
    Score: 0.278
  5. A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. PLoS One. 2016; 11(5):e0154778.
    View in: PubMed
    Score: 0.135
  6. Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015 Jul; 19(7):780-6.
    View in: PubMed
    Score: 0.128
  7. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. PLoS One. 2012; 7(11):e49898.
    View in: PubMed
    Score: 0.107
  8. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol. 2012 Apr; 50(4):1189-94.
    View in: PubMed
    Score: 0.100
  9. Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). Clin Infect Dis. 2023 02 08; 76(3):e580-e589.
    View in: PubMed
    Score: 0.054
  10. Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial. Am J Respir Crit Care Med. 2022 05 15; 205(10):1228-1235.
    View in: PubMed
    Score: 0.051
  11. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid. Clin Infect Dis. 2020 08 22; 71(5):1161-1167.
    View in: PubMed
    Score: 0.046
  12. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. N Engl J Med. 2017 09 14; 377(11):1043-1054.
    View in: PubMed
    Score: 0.037
  13. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet. 2017 Mar; 49(3):395-402.
    View in: PubMed
    Score: 0.035
  14. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother. 2014; 58(1):11-8.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.